Search results for "cholangiocarcinoma"

showing 10 items of 69 documents

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

2014

Pathologymedicine.medical_specialtyGlobal HealthPractice guidelinesPrimary sclerosing cholangitisCholangiocarcinomamedicineHumansIntrahepatic CholangiocarcinomaIntrahepatic cholangiocarcinomaEvidence-Based MedicineBiliary tract cancerHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyRecurrent Intrahepatic Cholangiocarcinomamedicine.diseaseBile Ducts IntrahepaticDiagnosis and managementBile Duct NeoplasmsPositron emission tomographyPractice Guidelines as TopicbusinessComparative genomic hybridizationContrast-enhanced ultrasoundJournal of Hepatology
researchProduct

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcino…

2020

Background: Systemic chemotherapy for pancreatic adenocarcinoma (PDAC) and cholangiocarcinoma (CC) with peritoneal metastases (PM) is affected by several pharmacological shortcomings and low clinical efficacy. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is expected to maximize exposure of peritoneal nodules to antiblastic agents. This study aims to evaluate safety and efficacy of PIPAC for PM of PDAC and CC origin. Methods: This is a retrospective analysis of consecutive PDAC and CC cases with PM treated with PIPAC at two European referral centers for peritoneal disease. We prospectively recorded from August 2016 to May 2019 demographic, clinical, surgical, and oncological data…

Peritoneal metastasismedicine.medical_treatmentSettore MED/18 - CHIRURGIA GENERALEpancreatic cancerPIPACcarcinomatosislcsh:RC254-282Pancreatic cancerMedicineDoxorubicincarcinomatosiOriginal ResearchCisplatinChemotherapybusiness.industrySystemic chemotherapyperitoneal metastaseaerosol chemotherapymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensdigestive system diseasesOxaliplatinperitoneal metastasesOncologyCancer researchlocoregional chemotherapyAdenocarcinomaPIPAC.businesscholangiocarcinomamedicine.drugTherapeutic Advances in Medical Oncology
researchProduct

Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment

2021

Several scoring systems have been devised to objectively predict survival for patients with intrahepatic cholangiocellular carcinoma (ICC) and support treatment stratification, but they have failed external validation. The aim of the present study was to improve prognostication using an artificial intelligence-based approach. We retrospectively identified 417 patients with ICC who were referred to our tertiary care center between 1997 and 2018. Of these, 293 met the inclusion criteria. Established risk factors served as input nodes for an artificial neural network (ANN). We compared the performance of the trained model to the most widely used conventional scoring system, the Fudan score. Pr…

Scoring systemTertiary careArticle03 medical and health sciences0302 clinical medicineintrahepatic cholangiocarcinomaMedicinesurvival predictionIntrahepatic Cholangiocarcinomarisk scoringTraining setFudan scoreArtificial neural networkbusiness.industryRExternal validationGeneral Medicineartificial intelligencemachine learningCholangiocellular carcinoma030220 oncology & carcinogenesisMedicine030211 gastroenterology & hepatologyArtificial intelligencebusinessRisk assessmentartificial neural networkJournal of Clinical Medicine
researchProduct

A systems biology perspective on cholangiocellular carcinoma development: focus on MAPK-signaling and the extracellular environment.

2008

Background/Aims Multiple genes have been implicated in cholangiocellular carcinoma (CCC) development. However, the overall neoplastic risk is likely associated with a much lower number of critical physiological pathways. Methods To investigate this hypothesis, we extracted all published genetic associations for the development of CCC from PubMed (genetic association studies, but also studies associating genes and CCC in general, i.e. functional studies in cell lines, genetic studies in humans, knockout mice etc.) and integrated CCC microarray data. Results We demonstrated the MAPK pathway was consistently enriched in CCC. Comparing our data to genetic associations in HCC often successfully …

SorafenibMAPK/ERK pathwayNiacinamideMAP Kinase Signaling SystemPyridinesSystems biologyAntineoplastic AgentsOncogenomicsBiologyCholangiocarcinomaMiceDatabases GeneticmedicineAnimalsHumansGeneOligonucleotide Array Sequence AnalysisHepatologyMicroarray analysis techniquesKinasePhenylurea CompoundsSystems BiologyBenzenesulfonatesComputational BiologySorafenibBiological EvolutionBile Ducts IntrahepaticBile Duct NeoplasmsMultigene FamilyImmunologyKnockout mouseCancer researchExtracellular Spacemedicine.drugJournal of hepatology
researchProduct

Intraductal aspiration: a promising new tissue-sampling technique for the diagnosis of suspected malignant biliary strictures

2012

Brushing is the most commonly used technique for biliary sampling at ERCP, despite its limited sensitivity. To evaluate intraductal aspiration (IDA) as a new combined endoscopic technique for cytodiagnosis, its cellular adequacy, diagnostic accuracy for cancer detection, feasibility, and safety. Prospective, observational study. Single tertiary referral center. IDA cellular adequacy, diagnostic accuracy for cancer detection, feasibility, and safety. From April 2009 to September 2010, 42 consecutive patients with suspected malignant biliary stricture underwent ERCP, with tissue sampling obtained with IDA. IDA included performance of standard brushing in all patients. After standard brushing,…

Suction (medicine)AdultMalemedicine.medical_specialtyCytodiagnosisConstriction PathologicCholangiocarcinomaPredictive Value of Testshemic and lymphatic diseasesBiopsymedicineHumansRadiology Nuclear Medicine and imagingSampling (medicine)Prospective StudiesProspective cohort studydiagnosis of suspected malignant biliary strictureIntraductal aspirationAgedAged 80 and overCholangiopancreatography Endoscopic RetrogradeCholestasisReceiver operating characteristicmedicine.diagnostic_testbusiness.industryBiopsy NeedleGastroenterologyTissue samplingMiddle AgedSurgeryCatheterBile Duct NeoplasmsPredictive value of testsFemaleGallbladder NeoplasmsRadiologyBile Ductsbusiness
researchProduct

Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives.

2020

Intrahepatic cholangiocarcinoma (iCCA) is the second most common hepatic malignancy and its incidence has been shown to increase significantly during the past decades. Complete surgical resection is currently acknowledged as the only curative treatment option able to provide adequate long-term outcomes. We herein review technical, functional and oncologic limitations for resectability, discuss current surgical aspects as well as highlight the fields in which future research and practice should focus on in order to ameliorate long-term outcomes in patients with iCCA.

Surgical resectionmedicine.medical_specialty030230 surgeryResectionBile duct cancerCholangiocarcinomaNeoplasms Multiple Primary03 medical and health sciences0302 clinical medicinePostoperative ComplicationsmedicineHepatectomyHepatic InsufficiencyHumansIn patientNeoplasm InvasivenessIntensive care medicineIntrahepatic Cholangiocarcinomabusiness.industryMargins of ExcisionGeneral Medicinemedicine.diseaseHepatic malignancyNeoadjuvant TherapyLiver TransplantationBile Ducts IntrahepaticOncologyBile Duct NeoplasmsCurative treatment030220 oncology & carcinogenesisBlood VesselsLymph Node ExcisionSurgeryLaparoscopyNeoplasm Recurrence LocalbusinessEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Limits of Surgical Resection for Bile Duct Cancer

2015

<b><i>Introduction:</i></b> Perihilar cholangiocarcinoma is the most frequent cholangiocarcinoma and poses difficulties in preoperative evaluation. For its therapy, often major hepatic resections as well as resection and reconstruction of the hepatic artery or the portal vein are necessary. In the last decades, great advances were made in both the surgical procedures and the perioperative anesthetic management. In this article, we describe from our point of view which facts represent the limits for curative (R0) resection in perihilar cholangiocarcinoma. <b><i>Methods:</i></b> Retrospective data of a 6-year period (2008-2014) was collected in …

Surgical resectionmedicine.medical_specialtyLimitsbusiness.industryGastroenterologyBile duct cancerReview Articlemedicine.diseasedigestive systemGastroenterologydigestive system diseasesBile duct cancerKlatskin tumorKlatskin tumorInternal medicineMedicineResectabilitySurgeryRadiologyPerihilar CholangiocarcinomabusinessPerihilar cholangiocarcinomaneoplasmsViszeralmedizin
researchProduct

Prognosis of resected intrahepatic cholangiocarcinoma

2017

Introduction. Complete resection stands as the only curative option for intrahepatic cholangiocarcinoma (IHCC). Still, prognosis remains poor after resection due to a recurrence rate over 60% leading to actual 5-year survival rates below 20%. Reliable prognostic estimation and better understanding of tumor biology would be of interest for improving IHCC prognosis.Methods. Using clinical and biological data from two large cohort of resected IHCC (MSKCC, n=189 and AFC, n=522), three objectives have been explored. First, assessing the performances of different published prognostic models. Second, defining the reliability of preoperative prognostic estimation using imaging, tumoral genomic prof…

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologySurvivalPrognostic modelsModèles pronostiquesRésectionGenomic profilingResectionCirculating microRNAGénomiqueCholangiocarcinome intrahépatiqueSurvie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyIntrahepatic cholangiocarcinomaMicroARN circulant
researchProduct

KRAS-mutated intrahepatic cholangiocarcinoma shows preferential sensitivity towards PARP-1-based interventions

2020

business.industryPoly ADP ribose polymeraseCancer researchmedicineSensitivity (control systems)KRASmedicine.disease_causebusinessIntrahepatic CholangiocarcinomaZeitschrift für Gastroenterologie
researchProduct

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tu…

2009

Metallothionein is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. Metallothionein has been shown to regulate apoptosis and proliferation. Overexpression of metallothionein frequently occurs in human tumors and is related to prognosis as well as therapy response. However, metallothionein expression and its clinical relevance in cholangiocarcinoma have not been investigated. The present study aimed to analyze metallothionein over-expression and its possible prognostic impact in intrahepatic cholangiocarcinoma and hilar extrahepatic cholangiocarcinoma (Klatskin tumors). We investigated the relationship of immunohistochemically demonstrated metalloth…

inorganic chemicalsMalePathologymedicine.medical_specialtyMedizinApoptosisHepatic Duct CommonBile Duct NeoplasmKaplan-Meier EstimateBiologydigestive systemPathology and Forensic MedicineBile duct cancerCholangiocarcinomamedicineBiomarkers TumorIn Situ Nick-End LabelingMetallothioneinHumansIntrahepatic CholangiocarcinomaNeoplasm Stagingurogenital systemBile ductCancerKlatskin's tumorMiddle Agedmedicine.diseasePrognosisImmunohistochemistrydigestive system diseasesUp-Regulationmedicine.anatomical_structureBile Ducts IntrahepaticKi-67 AntigenBile Duct NeoplasmsImmunohistochemistryFemaleMetallothioneinKlatskin Tumor
researchProduct